CVS raises 2021 profit view as COVID-19 vaccines, tests drive retail strength


FILE PHOTO: Shelves full of cigarettes are pictured at a CVS store in the Manhattan borough of New York February 5, 2014. REUTERS/Carlo Allegri

January 11, 2022

(Reuters) – CVS Health Corp on Tuesday raised its adjusted earnings forecast for 2021, citing strong retail sales helped by higher demand for COVID-19 vaccines as well as over-the-counter testing in November and December.

The company, best known for its chain of drugstores, raised its forecast for 2021 adjusted profit per share to a range of $8.33 to $8.38, up from at least $8.00 previously.

(Reporting by Ankur Banerjee and Manojna Maddipatla in Bengaluru; Editing by Ramakrishnan M.)





Source link

Leave a Reply

Your email address will not be published.

REGISTER

join the Patriot Network

Meet with other patriots

No censorship. Be free.